Ferrous Sulfate 325 MG tablet; NDC 33261-0715-00
Published May 23, 2018 · Recall initiated: April 10, 2018
Summary
FDA records drug Class III recall D-0810-2018, published May 23, 2018 and initiated April 10, 2018. Recalling firm: Aidarex Pharmaceuticals LLC; Status: Terminated; Reported quantity: 450 bottles; Lot: NDC 33261-0715-00 Batch ID: 57909-1, exp. date 04/30/2019 57909-2, exp. date 06/30/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Aidarex Pharmaceuticals LLC
- Distributor
- Product was distributed to Florida
- Lot
- NDC 33261-0715-00 Batch ID: 57909-1, exp. date 04/30/2019 57909-2, exp. date 06/30/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEnalapril Maleate, USP 5MG, 30-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: WockhardtAugust 1, 2018
- FDAEnalapril Maleate, USP 2.5MG, 90-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: WockhardtAugust 1, 2018
- FDAAcetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pak containers, Rx Only. Mnfct for:May 23, 2018
- FDANaturmetic SPF 50 Sunscreen (Octinoxate 7.5%, Zinc Oxide 10.5%), 2.0 fl oz/60mL bottles, Fortis BioPharma,May 23, 2018
- FDAENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles, Rx only, MFG: Wockhardt Ltd., India; Packaged By:November 1, 2017
- FDAPhentermine, USP Capsules, 15 mg, 30 count bottles, Rx only, Packaged By: Aidarex Pharmaceuticals, Corona, CA,September 20, 2017
Questions about this recall
Was Ferrous Sulfate 325 MG tablet; NDC 33261-0715-00 recalled?
Yes. FDA published recall D-0810-2018 on May 23, 2018. Reported hazard: Presence of Foreign Tablets/Capsules
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail